Download Citation
Article Source:
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting
Abernethy AP,
Arunachalam A,
Burke T,
McKay C,
Cao X,
et al.
(2017)
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.
PLOS ONE 12(6): e0178420.
https://doi.org/10.1371/journal.pone.0178420